The Association Between Psoriasis and Intestinal Bacterial Population
NCT02417792 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 46
Last updated 2019-09-25
Summary
At least 20 psoriasis patients will be compared to at least 20 participants without psoriasis Bacterial genomic DNA will be extracted from stool samples of participants. The intestinal bacterial populations will be compared in order to examine whether there are differences between the groups.
Conditions
Sponsors & Collaborators
-
Tel Aviv Medical Center
collaborator OTHER -
Assuta Hospital Systems
lead OTHER
Principal Investigators
-
Jonathan Shapiro, Dr. · Maccabi Healthcare Services, Israel
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-05-14
- Primary Completion
- 2019-01-06
- Completion
- 2019-02-18
More Related Trials
-
Study of Psoriatic Arthritis
NCT00001420 ·Status: COMPLETED
-
The Gut-Skin Axis Integrity in Psoriatic Patients
NCT04212507 ·Status: UNKNOWN
-
Cross-sectional Evaluation of Biological Markers of Cardiovascular Disease in Children and Adolescents With Psoriasis
NCT01122095 ·Status: UNKNOWN
-
Serum Level of Bioactive Mediators and Urinary Biopyrins in Psoriasis
NCT03889938 ·Status: UNKNOWN
-
Role of Chemokine and Chemokine Receptor in Psoriasis
NCT03302390 ·Status: WITHDRAWN
-
Tight Control Dose Reductions of Biologics in Psoriasis Patients With Low Disease Activity
NCT02602925 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate Apo805K1 in Subjects With Moderate to Severe Chronic Plaque Psoriasis
NCT01483924 ·Status: COMPLETED ·Phase: PHASE2
-
The Immunological Basis for Treatment Resistance to Anti-TNF Treatments
NCT01971346 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Investigate the Safety, Tolerability, Absorption, Distribution, Metabolism, and Elimination of RWJ-445380 Administered to Patients With Plaque Psoriasis
NCT00396422 ·Status: COMPLETED ·Phase: PHASE2
-
Understanding Participation Habits Among Plaque Psoriasis Patients
NCT06338358 ·Status: NOT_YET_RECRUITING
-
Multicenter Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis
NCT00645814 ·Status: COMPLETED ·Phase: PHASE2
-
MAP Study: Methotrexate and Adalimumab in Psoriasis
NCT03217734 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Assessment of Long-Term Infliximab for Psoriasis (P05319)
NCT00779675 ·Status: COMPLETED
-
Study Evaluating the Efficacy and Safety of Etanercept and Acitretin in Korean Patient With Moderate to Severe Psoriasis
NCT00936065 ·Status: COMPLETED ·Phase: PHASE4
-
Cytokine Expression in Psoriasis Patients with and Without Joint Involvement
NCT05307809 ·Status: RECRUITING ·Phase: NA
-
Psoriasis Longitudinal Assessment and Registry
NCT00508547 ·Status: ACTIVE_NOT_RECRUITING
-
Study to Evaluate Efficacy and Safety of MP1032 in Patients With Chronic Plaque Psoriasis
NCT03706209 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
NCT06671496 ·Status: RECRUITING ·Phase: PHASE3
-
The Impact of Targeted Therapy on Microorganism in Patients With Psoriasis
NCT01504113 ·Status: UNKNOWN
-
Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of CC-90006 in Subjects With Mild to Moderate Plaque-type Psoriasis
NCT03337022 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Efficacy of Enbrel as a Biological Treatment in Moderate to Severe Plaque Psoriasis Patients
NCT04398732 ·Status: COMPLETED
-
Randomized Double-Blind Placebo-Controlled Trial Using Recombinant Human Interleukin-10 for Moderate-to-Severe Psoriasis
NCT00001797 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical and Molecular Characterization of Axial Psoriatic Arthritis (PsA), A Pilot Study
NCT05925842 ·Status: UNKNOWN
-
Observational Safety Study of Etanercept (Enbrel) for Treatment of Psoriasis
NCT00322439 ·Status: COMPLETED
-
Study to Evaluate the Safety and Efficacy of JTE-051 in Subjects With Moderate to Severe Plaque Psoriasis
NCT03358290 ·Status: TERMINATED ·Phase: PHASE2